Skip to main content


Oncology Research


Cancer is a leading cause of death worldwide, accounting for 8.2 million deaths in 2012 (around 13% of all deaths). It is expected that global cancer cases will rise from 14 million in 2012 to 22 million within the next two decades.1 In Ireland, there are 20,454 new cases of cancer per year. 2

Janssen specializes in the treatment of breast cancer, lung cancer, prostate cancer, blood cancers and bowel cancer. Our ultimate goal is to make cancer a preventable, chronic or curable disease. We will achieve this by delivering extraordinary diagnostic and therapeutic solutions that prolong and improve patients’ lives. Our commitment to address the full continuum of cancer care sets us apart and our expertise in oncology is pushing us towards the next frontier – the era of personalised medicines.

Disease Backgrounders:

blood cancer

Blood Cancers

Multiple Myeloma (MM)

Prostate Cancer

Relapsed and Refractory Multiple Myeloma

Chronic Lymphocytic Leukaemia (CLL)

Mantle Cell Lymphoma (MCL)

Multicentric Castleman’s Disease (MCD)

Waldenström’s Macroglobulinemia (WM)

For more information, contact: 
The Irish Cancer Society

Janssen in Oncology

Make Blood Cancer Visible

The ‘Make Blood Cancer Visible’ campaign is a collaboration between Janssen, the Irish Cancer Society, CLL Ireland and Multiple Myeloma Ireland, in response to poor public awareness and understanding of blood cancers compared with other cancers. This lack of awareness can lead to many challenges for patients and their families in terms of accurate diagnosis, and access to support, information and appropriate treatments. 2018 marks the third year of the campaign.

Blood cancer is an umbrella term for cancers that affect the blood, bone marrow and lymphatic system. Most types of blood cancer are rare, life-threatening conditions with small patient population. There are over 140 different types of blood cancers, which can be classified into three main groups, leukaemia, lymphoma and myeloma. Together, they comprise nearly 10 per cent of all cancers, with more than 2,000 people across Ireland diagnosed annually. Blood cancer is the fourth most common cause of cancer-related death in Ireland.

In 2018 we conducted research with people living with cancer and their carers. Despite the significance of their caring role in terms of time commitment, the research revealed that almost two thirds (63%) of cancer carers received no support on how to carry out their role.To address the issues raised in the research, the Make Blood Cancer Visible campaign launched a series of information videos to provide practical advice and support for people living with blood cancer and their carers. Developed in conjunction with leading healthcare professionals and experts in the area of blood cancer care, the series addresses emotional wellbeing for carers and patients, diet and nutrition, and advice for carers.

We have been asking those impacted by blood cancer - patients, caregivers, family members, and healthcare professionals - to help make it more visible by sharing personal stories. These stories have been collated into a beautiful collection of personal stories from individuals across Europe affected by blood cancer, including an Irish man living with chronic lymphocytic leukaemia (CLL).

Make Blood Cancer Visible: Patient Perspectives


Man to Man: Irish Stories of Hope in Prostate Cancer, the storybook is a collection of real-life inspiring stories of hope from men with prostate cancer and is designed to offer hope and support to other men with their diagnosis and promote greater psychological supports for those living with the illness. Developed by Janssen, the pharmaceutical division of Johnson & Johnson, in association with the Irish Cancer Society, the storybook is the result of research with people who have been affected by prostate cancer to find out what type of information would help them on their journey to recovery. The research found that not only do other men with prostate cancer find comfort in hearing a real Irish story, doctors and nurses can also draw on those experiences in order to further improve the treatment journey for others.

“The Prostate Cancer: Living, not Just Surviving report, developed by Janssen EMEA in collaboration with several European prostate cancer patient associations, highlights findings from a pan-European survey of prostate cancer patients, caregivers and healthcare professionals.

The report calls for a greater focus on addressing the quality of life needs of men living with prostate cancer in Europe. The report reveals insights into the emotional, social and physical issues faced by prostate cancer patients, their caregivers and their families and aims to raise awareness of the need to improve quality of life for those affected by the disease.”

Man to Man : Irish Stories of Hope in Prostate Cancer

Prostate Cancer: Living, not Just Surviving


1WHO Cancer Factsheet 
Last accessed May 2016

2 National Cancer Registry (Last accessed May 2016)

3Empathy Research of 1,000 Irish Adults. February 2016.